From working to develop one of the first nonhuman primate models for the 2019 novel coronavirus disease (COVID-19) to designing new nanotechnology-based tests to rapidly diagnose infections, researchers at Tulane University are responding across disciplines to the emerging coronavirus epidemic.
Professor James “Mac” Hyman's goal is to help the public health community better understand and predict the spread of the COVID-19 and to quantify the effectiveness of various efforts to stop it.
Data scientists analyzing genetic sequences of the COVID-19 coronavirus have identified potential vulnerabilities that could help in vaccine development and further study of the infectious disease now spreading worldwide.
By: Bill Wellock | Published: February 14, 2020 | 3:35 pm | SHARE: As an outbreak of a new coronavirus makes headlines across the world, another more common infectious disease is spreading across the United States and beyond — the flu.About 8 percent of the U.S. population gets sick from the flu each season, according to the Centers for Disease Control and Prevention.
While travel bans are frequently used to stop the spread of an emerging infectious disease, a new University of Washington and Johns Hopkins University study of published research found that the effectiveness of travel bans is mostly unknown.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
